IR-News

AUSSENDER



Medigene AG
Ansprechpartner: Medigene PR/IR
Tel.: +49 89 2000 33 3301
E-Mail: investor@medigene.com

FRüHERE MELDUNGEN

pta20180608035
Release according to article 40 para. 1 WpHG

Medigene AG: Release according to Article 40, Section 1 of the WpHG

Voting Rights Announcement


Planegg (pta035/08.06.2018/19:35) - Release of Voting Rights Announcement

Voting Rights Announcement

1. Details of issuer:

Name: Medigene AG
Legal Entity Identifier (LEI): 391200I33JD2DKZGDX06
Street: Lochhamer Straße 11
Postal code: 82152
City: Planegg, Germany

2. Reason for notification:
Acquisition / disposal of shares with voting rights

3. Details of person subject to the notification obligation
Legal entity: QVT Financial GP LLC
City of registered office, country: Dover, Delaware, United States of America (USA)

4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3
QVT Family Office Fund LP

5. Date on which threshold was crossed or reached
25.05.2018

6. Total positions

% of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG
New 4.81 0.00 4.81 22,313,732
Previous notification (if applicable) 9.84 9.84

7. Details on total positions

a. Voting rights attached to shares (Sec.s 33, 34 WpHG)

ISIN Absolute direct (Sec. 33 WpHG) Absolute indirect (Sec. 34 WpHG) In % direct (Sec. 33 WpHG) In % indirect (Sec. 34 WpHG)
DE000A1X3W00 0 1,072,879 0.00 4.81
Total: 1,072,879 4.81

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG

Type of instrument Maturity / Expiration Exercise or conversion period Voting Rights Absolute Voting Rights in %
Total:

b.2 Instruments according to Sec. 38 (1) no. 2 WpHG

Type of instrument Maturity / Expiration Exercise or conversion period Cash or physical transaction Voting Rights Absolute Voting Rights in %
Total:

8. Information in relation to the person subject to the notification obligation

Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
QVT Financial GP LLC
QVT Financial LP 4.81

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting: N/A

10. Other useful information


Date
N/A

(end)
emitter: Medigene AG
Lochhamer Straße 11
82152 Planegg
Germany
contact person: Medigene PR/IR
phone: +49 89 2000 33 3301
e-mail: investor@medigene.com
website: www.medigene.de
stock exchanges: regulated market in Frankfurt; free market in Dusseldorf, free market in Hamburg, free market in Hannover, free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate
ISIN(s): DE000A1X3W00 (share)
|
|
98.769 Abonnenten
|
203.257 Meldungen
|
83.981 Pressefotos

BUSINESS

30.09.2022 - 14:40 | SRH AlsterResearch AG
30.09.2022 - 14:35 | SRH AlsterResearch AG
30.09.2022 - 14:35 | SRH AlsterResearch AG
30.09.2022 - 14:00 | Financial Planning Standards Board Deutschland e.V.
30.09.2022 - 13:00 | pressetext.redaktion
Top